With the right approach, most men can continue benefiting from TRT while improving their sleep, comfort, and overall quality of life
Blossom Inuenwi, DNP, evaluates each patients unique concerns, lifestyle, and weight management objectives to develop an individualized care approach
This study represents a significant step forward in closing the treatment gap for BBS and demonstrates how targeting central satiety pathways with GLP-1 therapies may benefit patients whose conditions have long lacked effective medical options, said senior author Guillaume de Lartigue, PhD , Monell Associate Member
Ozempic is FDA-approved to treat Type 2 diabetes, and Wegovy is FDA-approved for weight loss
Subcutaneous injections with such tiny needles tend to be relatively painless